Print this page

Il commento del Prof. Carlo Caltagirone, direttore scientifico della Fondazione Santa Lucia, all'abbandono della linea di ricerca farmacologica sull'Alzheimer da parte della Pfizer.

Read 1596 times
Rate this item
(0 votes)
Last modified on Thursday, 18 January 2018 10:11
Login to post comments

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie Policy